Drugmakers Lean on AI to Accelerate Trials and Regulatory Workflows
Leading pharmaceutical and smaller biotech companies described how artificial intelligence is already shortening labor-intensive drug development tasks such as finding trial participants and preparing regulatory documents. While the technology has yet to produce the next transformative therapeutic molecule, attendees at a major industry conference …